A new grad with two offers on the kitchen table this week is not choosing between "corporate" and "independent." Both offers are corporate. One says VCA on the letterhead. The other says NVA. They are not the same job, and the differences show up in the first paycheck, not the tenth.
Mars Veterinary Health, IVC Evidensia, and NVA between them employ a meaningful share of practicing vets in North America. Mars Veterinary Health alone counts nearly 70,000 associates worldwide, including more than 12,000 veterinarians, across Banfield, VCA, and BluePearl, according to the company's own numbers on marsveterinary.com. Lump the three consolidators together in a job search and you'll miss real structural differences in comp, autonomy, and what happens to your name on the door.
Three Owners, One Word
"Corporate" hides three different ownership stories. Mars Veterinary Health is a strategic buyer, not a private-equity fund, backed by a family-owned confectionery and pet-care company that isn't working toward an exit. IVC Evidensia is owned by EQT, a Swedish private equity group, and runs almost 2,500 clinics across 20 countries, per its own "About" page. NVA is owned by JAB Holding, the Reimann family's Luxembourg-based investment vehicle, which acquired NVA in 2019 and has been reshaping it since.
That reshaping matters right now. In 2023, NVA split into two businesses: NVA, which now runs general practice hospitals, pet resorts, and equine practices, and Ethos Veterinary Health, which took the specialty and emergency side, including the former Compassion-First and Sage Veterinary Centers hospitals, with 145 specialty locations, according to AVMA's JAVMA News. If your offer letter says NVA today, you're being hired into the general-practice half of what used to be one company. If it says Ethos, you're in the specialty half. Same lineage, different employer now.
The Paycheck Looks Different by Logo
VCA's own recruiting language, repeated across dozens of its individual hospital career pages, says its doctors "practice medicine their way, with no corporate restrictions, quotas, or flowcharts," and offers "production plans without negative accrual." Negative accrual is the detail that actually matters: it determines whether a slow month gets carried forward against you or just quietly absorbed. VCA's stated position is the latter.
NVA's general-practice job postings on careers.nva.com show a different structure: a base salary starting around $125,000 for new graduates, a production bonus in the low-20-percent range, and signing bonuses reported around $25,000 in some listings. That's a base-plus-production model, not a straight commission split.
Banfield, also under Mars, runs on a more standardized chassis. It operates most of its 1,000-plus hospitals inside PetSmart stores and built its own proprietary electronic record system, PetWare, which it has used since the mid-1980s to track visits across its network, the company says. Its Optimum Wellness Plans standardize preventive-care bundles pet owners buy up front. A Banfield doctor is working inside more corporate scaffolding, day to day, than a VCA doctor down the street who happens to share a parent company.
Whose Name Stays on the Door
This is where the three groups diverge hardest. VCA's model has historically kept legacy hospital names alongside the VCA brand rather than renaming everything uniformly; whether a practice becomes "a VCA hospital" or stays "Dr. Smith's Animal Hospital, a VCA practice" is a real negotiating point in acquisitions, not a formality, because long-tenured staff and clients are attached to the old name, not the parent company.
IVC Evidensia describes a similarly decentralized approach on its own site, saying it promotes "clinical freedom" balanced against shared support functions like procurement and clinical advisory boards. In North America, that mostly runs through VetStrategy, which merged into IVC Evidensia in November 2021 and operates more than 360 hospitals across every Canadian province, per IVC Evidensia's own materials.
Banfield is the outlier again. Its hospitals carry the Banfield name and the Banfield protocols, full stop. There's no "Dr. Smith's, a Banfield practice" version of the brand. If keeping your own name matters to you professionally, that's a Banfield-shaped no before you even get to compensation.
The Ownership Question
NVA is the one of the three actively marketing a path back to ownership. Its Joint-Venture Partnership program, described on gp.nva.com, is pitched as a way to move from associate to partner "without the financial burden" of buying a practice outright, while keeping "the perks of a larger company." NVA's own career materials frame this as a deliberate arc: new grads build clinical skills, mid-career doctors take on leadership, and "seasoned" veterinarians move toward practice ownership through the program.
We checked the public career and corporate sites for Banfield, VCA, and BluePearl and found no equivalent local-ownership or joint-venture program advertised in the same way. That doesn't mean individual deals never happen at Mars-owned brands, but there's no public program built around it the way there is at NVA. IVC Evidensia's public materials center on its Graduate Academy and mentorship rather than a stated equity pathway for North American associates; new graduates get a "dedicated practice-based Vet GDP Advisor" or Academy Clinical Coach for their first role, per the company's own program page.
Before You Sign
Ask three questions that these companies answer differently, on the record, right now: does the production model carry negative accrual month to month, does your name change to the parent brand or stay local, and is there an actual documented path to equity, or just a verbal maybe. NVA has a named program for the third question. VCA has a public position on the first. Banfield has already answered the second for you. Get the answer to all three in writing before you compare offers by salary line alone, because the salary line is the part these three groups have made least different from each other.